Respiratory & Infectious Disease

Pneumococcal Clinical Research

Pneumococcal disease remains a major global health concern, affecting children, older adults, and immunocompromised populations. CenExel partners with sponsors to advance innovative vaccines and therapies through scientifically rigorous clinical research and patient-focused trial execution.

Studies Conducted
0 +
Trial Participants
0 +
Active Sites
0 +
Overview

Advancing Pneumococcal Vaccine & Treatment Research

CenExel provides comprehensive clinical research support for pneumococcal vaccine and infectious disease studies. Our experienced investigators and operational teams help sponsors accelerate timelines, improve enrollment, and deliver high-quality data from early-phase trials through post-market studies.

Improve Vaccine Development

Accelerate vaccine and therapeutic research with experienced infectious disease investigators and advanced clinical infrastructure.

Diverse Patient Recruitment

Access broad and diverse patient populations across multiple U.S. research sites for faster enrollment and stronger data outcomes.
Conditions Covered

Pneumococcal Conditions We Research

Our research teams support a broad range of pneumococcal and respiratory infectious disease studies for pediatric, adult, and elderly populations.

  • Pneumococcal Pneumonia
  • Invasive Pneumococcal Disease (IPD)
  • Community-Acquired Pneumonia
  • Bacterial Respiratory Infections
  • Pediatric Pneumococcal Disease
  • Adult Pneumococcal Vaccination
  • Elderly Immunization Studies
  • Antibiotic Resistance Studies
Our Approach

Why Sponsors Choose CenExel for Pneumococcal Research

CenExel combines infectious disease expertise, advanced recruitment strategies, and operational excellence to support successful pneumococcal clinical trials.

01

Infectious Disease Expertise

Experienced investigators and coordinators specializing in respiratory and vaccine research.

02

Rapid Enrollment

Efficient patient recruitment strategies across multiple high-performing research sites.

03

Advanced Vaccine Trial Support

Support for Phase I-IV vaccine and therapeutic studies with strong data quality standards.

04

Nationwide Research Network

Access to geographically diverse populations and centralized operational support.

Phase Coverage

Supported Clinical Trial Phases

CenExel supports pneumococcal and infectious disease studies from first-in-human vaccine trials through large-scale post-marketing research.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Pneumococcal Research Task Force

CenExel supports vaccine and infectious disease sponsors with specialized respiratory research capabilities, rapid enrollment, experienced investigators, and access to diverse patient populations.

Active Sites

18 Sites

CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg

Our Blog